Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Aug-24 5:12 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Option Exercise | 14,100 | $73.60 | $1,037,760.00 | 45% 31.53K to 45.63K | 4% |
| 15-Aug-24 5:12 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Planned Private Option Sale | 14,100 | $150.38 | $2,120,350.00 | (31%) 45.63K to 31.53K | |
| 18-Jul-24 4:45 PM View: | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Option Exercise | 900 | $73.60 | $66,240.00 | 3% 31.53K to 32.43K | 4% |
| 18-Jul-24 4:45 PM View: | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Planned Private Option Sale | 900 | $150.04 | $135,037.00 | (3%) 32.43K to 31.53K | |
| 16-May-24 4:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 15-May-24 | Option Exercise | 15,000 | $73.60 | $1,104,000.00 | 48% 31.53K to 46.53K | |
| 16-May-24 4:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 15-May-24 | Planned Option Sale | 15,000 | $140.24 | $2,103,610.00 | (32%) 46.53K to 31.53K | |
| 16-May-24 4:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 14-May-24 | Option Exercise | 15,000 | $73.60 | $1,104,000.00 | 48% 31.53K to 46.53K | 4% |
| 16-May-24 4:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 14-May-24 | Planned Private Option Sale | 15,000 | $135.65 | $2,034,830.00 | (32%) 46.53K to 31.53K | |
| 15-Feb-24 5:27 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 1,352 | $132.85 | $179,612.00 | (4%) 32.88K to 31.53K | |
| 08-Feb-24 7:12 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-24 | Sale (Planned) | 980 | $134.21 | $131,529.00 | (3%) 31.29K to 30.31K | |
| 08-Feb-24 7:12 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-24 | Private Sale (Planned) | 1,280 | $142.19 | $182,000.00 | (4%) 30.71K to 29.43K | |
| 02-Feb-24 7:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 1,283 | $140.72 | $180,539.00 | (4%) 29.57K to 28.28K | |
| 23-Aug-23 7:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 2,132 | $107.39 | $228,958.00 | (7%) 29.26K to 27.13K | |
| 08-Feb-23 7:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 980 | $104.19 | $102,110.00 | (4%) 26.19K to 25.21K | |
| 08-Feb-23 7:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 26,328 | $102.40 | $2,696,110.00 | (52%) 50.66K to 24.33K | |
| 08-Feb-23 7:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 1,280 | $105.67 | $135,253.00 | (5%) 23.79K to 22.51K | |
| 02-Feb-23 4:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 1,283 | $109.98 | $141,108.00 | (6%) 22.64K to 21.36K | |
| 09-Feb-22 6:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 980 | $79.65 | $78,057.60 | (5%) 21.18K to 20.2K | |
| 09-Feb-22 6:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 3,310 | $80.79 | $267,428.00 | (15%) 22.64K to 19.32K | |
| 03-Dec-21 5:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Dec-21 | Market Sale (Planned) | 1,645 | $82.59 | $135,852.00 | (9%) 17.99K to 16.35K | 2% |
| 09-Feb-21 9:30 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-21 | Market Sale (Planned) | 2,910 | $116.82 | $339,942.00 | (16%) 17.78K to 14.87K | 1% |
| 02-Dec-20 4:12 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Dec-20 | Market Sale (Planned) | 1,645 | $94.66 | $155,721.00 | (13%) 13.14K to 11.49K | (22%) |
| 16-Nov-20 6:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Nov-20 | Market Sale (Planned) | 2,257 | $90.74 | $204,810.00 | (18%) 12.27K to 10.01K | (27%) |
| 07-Aug-20 6:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-20 | Market Sale (Planned) | 2,257 | $118.90 | $268,356.00 | (22%) 10.24K to 7.98K | 3% |
| 11-May-20 8:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-May-20 | Option Exercise | 15,000 | $73.60 | $1,104,000.00 | 252% 5.95K to 20.95K | |
| 11-May-20 8:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-May-20 | Market Option Sale (Planned) | 15,000 | $110.21 | $1,653,130.00 | (72%) 20.95K to 5.95K | (5%) |
| 30-Apr-20 4:25 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Apr-20 | Market Sale (Planned) | 1,741 | $102.49 | $178,435.00 | (23%) 7.69K to 5.95K | (13%) |
| 28-Apr-20 8:32 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-20 | Market Sale (Planned) | 1,934 | $99.52 | $192,467.00 | (20%) 9.63K to 7.69K | (16%) |
| 11-Feb-20 7:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-20 | Market Sale (Planned) | 2,030 | $103.35 | $209,807.00 | (26%) 7.73K to 5.7K | (12%) |
| 04-Dec-19 6:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Dec-19 | Market Sale (Planned) | 1,645 | $116.33 | $191,360.00 | (30%) 5.52K to 3.88K | < 1% |
| 06-Dec-18 5:54 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Dec-18 | Market Sale (Planned) | 1,178 | $90.00 | $106,020.00 | (38%) 3.13K to 1.95K | (28%) |